Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2000
12/27/2000EP1061940A2 Use of follistatin to modulate gdf-8 and bmp-11
12/27/2000EP1061937A1 Improved radiation therapy methods
12/27/2000EP1061936A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders
12/27/2000EP1061934A1 Fibrinogen receptor antagonists
12/27/2000EP1061926A2 Heterocyclic compounds, their production and use as tachykinin receptor antagonists
12/27/2000EP1061923A2 Metal chelators for use in the treatment of alzheimer's disease
12/27/2000EP1061921A1 Vitronectin receptor antagonists
12/27/2000EP1061919A1 Novel opiate compounds, methods of making and methods of use
12/27/2000EP1061918A1 Controlled release composition of (1-azabicyclo(2.2.2)oct-3-yl)acetonitrile monohydrochloride
12/27/2000EP1061917A1 Methods of inhibiting bone resorption
12/27/2000EP1061916A2 Use os nitrone compounds for the inhibition of angiogenesis
12/27/2000EP1061914A1 Lipoic acid analogs
12/27/2000EP1061912A1 Phenanthrofuran derivatives
12/27/2000EP1061911A2 Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are affected
12/27/2000EP1061910A1 Use of alpha-rar antagonists for inhibition of mucin secretion
12/27/2000EP1061909A1 Keto acid salts and amine derivatives, and their use for preparing medicines
12/27/2000EP1061908A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions
12/27/2000EP1061812A1 Food products having enhanced cocoa polyphenol content and processes for producing same
12/27/2000EP1061803A1 Novel compositions of eprosartan
12/27/2000EP1061800A1 Compositions and methods for modulating vascularization
12/27/2000EP0891322B1 Dimethyl-substituted cyclohexane diene derivatives
12/27/2000EP0882015B1 Diphenyl stilbenes as prodrugs to cox-2 inhibitors
12/27/2000EP0823900B1 Quinazoline derivatives
12/27/2000EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
12/27/2000EP0821666B1 Derivatives of succinamide and their use as metalloproteinase inhibitors
12/27/2000EP0671909B1 Syndecan stimulation of cellular differentiation
12/27/2000CN1278255A Cyclopentene derivatives useful as antagonists of the motilin receptor
12/27/2000CN1278252A 4,5-diaryloxazole compounds
12/27/2000CN1278251A Novel carboxylic acid derivatives which carry amide side chains, prodn. of same, and use as endothelin receptor antagonists
12/27/2000CN1278250A Vitronectin receptor antagonists
12/27/2000CN1278247A Alpha-hydroxy, amino and -fluoro derivatives of beta-sulphenyl hydroxamic acids matrix metalloproteinases inhibitors
12/27/2000CN1278245A Malonic acid based matric metalloproteinase inhibitors
12/27/2000CN1278183A Soluble MHC complexes and methods of use thereof
12/27/2000CN1278182A Citrus peel extract as inhibitor of acyl CoA-cholesterol-0-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall
12/27/2000CN1278176A Use of quinazoline derivatives as tyrosine kinase inhibitors for treating colonic polyps
12/27/2000CN1278172A Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function
12/27/2000CN1278171A Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, ihibitor of macrophage-lipid complex accumulation on the arterial wall and preventive agent
12/27/2000CN1278170A Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive agent
12/27/2000CN1277962A Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
12/27/2000CN1277961A Novel 2,3-methylene amino acid compound, prepn. method therefor, pharmaceutical compositions contg. same
12/27/2000CN1277853A Anti-fatigue farmaceutical and its prepn. process
12/27/2000CN1059826C Traditional Chinese medicine liquor for decreasing abdomen
12/27/2000CN1059825C Method for extracting and separating flavone and terlactone from ginkgo leaf by supercritical carbon dioxide
12/27/2000CN1059824C Compound traditional Chinese medicine prepns. for treating silicosis, and prepn. method therefor
12/27/2000CN1059819C Traditional Chinese medicine for reinforcing kidney and enhancing fitness of female old-aged people
12/27/2000CN1059818C Traditional Chinese medicine preparation for invigrating brain tonifying and enhancing fitness of female teen-agers
12/27/2000CN1059817C Traditional Chinese medicine preparation for reinforcing the kidney and enhancing fitness of old-age people
12/27/2000CN1059816C Traditional Chinese medicine preparation for reinfocing kidney and enhancing fitness of female middle-aged persons
12/27/2000CN1059815C Traditional Chinese medicine preparation for reinforcing the kidney and enhancing fitness of middle-aged male persons
12/27/2000CN1059814C Traditional Chinese medicine preparation for invigorating brain and enhancing fitness of ten-agers
12/26/2000US6166227 Preparation of (S)-2-amino-6, 6-dimethoxyhexanoic acid methyl ester via novel dioxolanes
12/26/2000US6166221 Intermediate for 4-(hydroxy-5-(1-imidazolyl)-2-methylbenzyl)-3,5-dimethylbenzoic acid useful as a thromboxane synthetase inhibitor and an agent for the prophylaxis and treatment of diabetes
12/26/2000US6166219 Treatment of diabetes and related disorders
12/26/2000US6166178 Polypeptide for the treatment of cancer; anticarcinogenic agents
12/26/2000US6166090 Prevention atherosclerosis; administering transforming growth factor
12/26/2000US6166087 Immunosuppresants, antiinflammatory agents, antitumor agents;applying to mucous membranes
12/26/2000US6166086 Small molecules that increase the conversion of food to body weight gain
12/26/2000US6166084 Compositions for the treatment of chronic wounds
12/26/2000US6166077 Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1
12/26/2000US6166074 Pharmaceutical compositions
12/26/2000US6166063 Antidiabetic agents; antiarthritic agents; osteoporosis
12/26/2000US6166055 Antiinflammatory agents
12/26/2000US6166049 A treatment and/or prophylaxis of hyperglycaemia, pre-diabetic insulin resistance syndrome by administering an agonist of peroxisome proliferator-activated receptor to stimulate fatty oxidation
12/26/2000US6166048 Pharmaceutical compositions for inhibition of cytokine production and secretion
12/26/2000US6166046 A synergistic mix ratio
12/26/2000US6166043 Insulin sensitivity enhancer such as pioglitazone in combination with a biguanide such as metformin
12/26/2000US6166042 Pharmaceutical composition
12/26/2000US6166040 Treating a disorder of the central nervous system
12/26/2000US6166039 Peripherally active anti-hyperalgesic opiates
12/26/2000US6166035 1,4-dihydropyridine derivatives and their use in therapy
12/26/2000US6166034 Spiro piperidine derivatives as 5HT1D receptor antagonists
12/26/2000US6166030 An inhibitors of the neuronal isoform of nitric oxide synthase; treating hypoxia, stroke, ischaemia, neurodegenerative conditions, schizophrenia, pain, migraine
12/26/2000US6166025 A stable, aqueous drug formulation for treating migraine
12/26/2000US6166022 Treatment of platelet aggregation disorders and angina
12/26/2000US6166020 Aryl and heteroaryl alkoxynaphthalene derivatives
12/26/2000US6166015 Pyrrolidine derivatives-CCR-3 receptor antagonists
12/26/2000US6166005 Heterocyclic metalloprotease inhibitors
12/26/2000US6165999 Tetracycline derivatives
12/26/2000US6165997 Phospholipids having antimicrobial activity with or without the presence of antimicrobials
12/26/2000US6165984 Administering an effective amount of naringin or naringenin to the human to prevent acylcoa-cholesterol-o-acyltransferase activity to treat hepatic diseases; inhibiting accumulation of macrophage-lipid complex on the arterial endothelium
12/26/2000US6165983 Use of collagen for the treatment of degenerative articular processes
12/26/2000US6165975 Microdose therapy
12/26/2000US6165790 Antisense modulation of PI3 kinase p55 gamma expression
12/26/2000US6165732 Drug screening by using lipid bilayer that has potassium- or chloride-selective channel formed from polpeptide of bcl-2 family, contacting compound with bilayer, and determining ion-selectivity of channel; indicates agonist or antagonist
12/26/2000US6165720 Conjugating nucleic acid with a peptide nucleic acid in a sequence-specific manner prior to transfection, transfecting cell with conjugate, and monitoring intracellular location
12/26/2000US6165515 Administering to the osteoporosis patient an effective amount of an extract from inflammatory tissue of rabbit skin inoculated with vaccinia virus, which is protein free hygroscopic powder, and is positive for ninhydrin reaction
12/26/2000US6165476 Fusion proteins with an immunoglobulin hinge region linker
12/26/2000US6165465 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody
12/26/2000US6165464 Monoclonal antibodies directed to the HER2 receptor
12/26/2000US6165462 Sugar kinase
12/26/2000US6165461 Tao protein kinases and methods of use therefor
12/26/2000CA2182476C Macrocyclic difluorostatone derivatives useful as antiviral agents
12/21/2000WO2000077256A1 48 human secreted proteins
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077246A2 A METHOD FOR IDENTIFYING A DRUG CANDIDATE HAVING AN INHIBITORY ACTION ON FVII-TF ACTIVITY, AND FVIIa/TF ACTIVITY INHIBITING COMPOUNDS
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077233A2 Complement-resistant non-mammalian dna viruses and uses thereof
12/21/2000WO2000077226A1 22025, a novel human cyclic nucleotide phosphodiesterase
12/21/2000WO2000077210A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf)
12/21/2000WO2000077207A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto